The global predictive genetic testing and consumer genomics market is expected to soar through 2025, according to a Research and Markets report.
Here are four things to know about the market.
- It's projected to reach $4.6 billion by 2025.
- This market growth is attributed to growing awareness of genomic tests and increasing availability of direct-to-consumer products.
- Its key market players include BGI, Illumina, Pathway Genomics, Genesis Genetics and 23andMe.
- The largest share of predictive testing is attributed to breast and ovarian cancer. Looking forward, genetic tests related to gynecology and endocrinology have generated interest.
Click here to view the full report.